Arvinas, Inc. (NASDAQ:ARVN) is among the best US stocks under $10 to invest in. XTX Topco Ltd has increased its stake in ...

Arvinas Inc. (NASDAQ:ARVN) is one of the best small cap stocks with biggest upside potential. On August 8, Arvinas, in ...

There's been a notable change in appetite for Arvinas, Inc. (NASDAQ:ARVN) shares in the week since its quarterly report, with the stock down 15% to US$6.29. Revenue was dismal, with revenues of US$22m ...

Arvinas Inc. Annual stock financials by MarketWatch. View the latest ARVN financial statements, income statements and financial ratios.

For example, Arvinas, Inc. (NASDAQ:ARVN) shareholders have seen the share price rise 80% over three years, well in excess of the market return (41%, not including dividends).

Arvinas is headquartered in New Haven, Connecticut. For more information about Arvinas, visit www.arvinas.com and connect on LinkedIn and X. Contacts Investors: Jeff Boyle +1 (347) 247-5089 ...

Arvinas had a negative net margin of 75.51% and a negative return on equity of 33.75%. During the same quarter in the previous year, the business earned ($2.53) earnings per share.

Yale spinout and 2015 Fierce 15 company Arvinas, a biotech working on small-molecule protein degradation therapies, has penned a deal potentially worth $830 million, and more besides, with Big Phar ...

Arvinas has also granted the underwriters a 30-day option to buy an additional 857,142 shares at the public offering price. The $400 million offering is expected to close on Friday, subject to ...

The stock price of Arvinas (NASDAQ: ARVN), a biopharmaceuticals company focused on oncology treatments based on targeted protein degradation, reached an all-time high of $108 in July of this year ...

Arvinas on Wednesday said Houston, who has been president and chief executive of the New Haven, Conn., company since September 2017, will retire from those positions upon the appointment of a ...